MuriGen Therapeutics is an Australian based drug discovery and development company
established by the Walter and Eliza Hall Institute of Medical Research.

MuriGen is building a portfolio of novel drugs for unmet medical needs across a number of therapeutic areas including cancer, arthritis, thrombocytopenia, inflammation and thalassemia. By leveraging its proprietary drug discovery platform, MuriGen Therapeutics is working towards the validation of novel drug targets that have the potential to provide significant benefits for researchers, health care practitioners, and patients.

Latest News